Upcoming Event: 3rd Annual Clinical Trials & Outsourcing Asia Congress
11/7/2013
Event: 3rd Annual Clinical Trials & Outsourcing Asia Congress
Dates: February 27 - 28, 2014
Venue: InterContinental Hotel Shanghai, Shanghai, China
Contact: Freda Shi
Tel: +65 6570 2208
The growth of clinical activities in Asia and Asia Pacific is so significant that industry leaders believe that the Asia market will overtake the US by 2020. With the increasing interest these recent years, the congress will explore into discussing issues such as global and local clinical development strategies in oncology and other therapeutic areas in order to maximize the success from CRO selection.
Attend our 3rd Annual Clinical Trials & Outsourcing Asia Congress to explore into the invaluable insights of novel clinical development, clinical outsourcing strategies, biomarker clinical research and clinical trial management. Join us at InterContinental Hotel Shanghai, Pudong on 27th & 28th February 2014, this insightful event will attract over 150 senior level decision markers representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
New focus
Pharmaceutical companies have put substantial efforts into research to discover biomarkers yet there is still a long way to go to translate this into clinical practice. The next step in the process for pharmaceuticals is to qualify and validate the application of biomarkers before they can be safely used in clinical practice. Therefore, with the new Biomarkers stream addition to the 3rd Annual Clinical Trials & Outsourcing Asia Congress, this event is not to be missed.
To build on the clinical case studies shared at last year's event, we are pleased to introduce the co-located '4th Annual Pharma R&D Asia Congress' focusing on discussions on innovative strategies to overcome these R&D issues and help accelerate development pipelines.